Evidence map›Paper›PMID 40874106›Full record

ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2025

Do not disturb: Use of wearable biosensor technology to minimize sleep disruptions in patients with hematological malignancies.

Natalie D Iannucci, Charlene H Chu

Abstract read
In one paragraph

Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Natalie D IannucciMN Student, Lawrence Bloomberg Faculty of Nursing, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON.
Charlene H ChuAssistant Professor, Lawrence Bloomberg Faculty of Nursing, University of Toronto; Cross-appointed, Rehabilitation Sciences Institute, Toronto, ON; Cross-appointed, Institute for Life Course and Aging, Toronto, ON; KITE-Toronto Rehab, University Health Network, Toronto, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with hematological malignancies frequently suffer from sleep disruptions during hospitalization, primarily due to frequent night-time interventions such as vital signs monitoring, which occurs at least three times during the night shift. Consequently, the sleep of these patients is interrupted each time a nurse checks their vitals. Minimizing disturbances to sleep in cancer patients is essential, as poor sleep quality has been associated with poorer responses to treatment and reduced overall survival (Strøm et al., 2022). This paper proposes the use of wearable biosensor technology over night in the inpatient setting to monitor patients' vital signs remotely and, thus, minimize disruptions to their sleep. The importance of improving sleep in this patient population and the potential for use of this technology necessitates further research on the analytical and clinical validity of wearable biosensors for use with hospitalized malignant hematology patients. The paper concludes with future recommendations and implications of this technology for the nursing profession.

Identifiers

PMID40874106
PMCPMC12379872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.